428.03

2.88% 11.99

Medpace Holdings Inc (MEDP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$416.04

Offen:

$421.445

24-Stunden-Volumen:

672.77K

Relative Volume:

2.35

Marktkapitalisierung:

$12.15B

Einnahmen:

$2.36B

Nettoeinkommen (Verlust:

$433.01M

KGV:

29.94

EPS:

14.2984

Netto-Cashflow:

$676.77M

1W Leistung:

-21.03%

1M Leistung:

-29.65%

6M Leistung:

-8.54%

1J Leistung:

+25.01%

1-Tages-Spanne:

$421.44

$442.41

1-Wochen-Bereich:

$392.35

$547.07

52-Wochen-Spanne:

$250.05

$628.92

Medpace Holdings Inc Stock (MEDP) Company Profile

Firmenname

Medpace Holdings Inc

Sektor

Healthcare (1111)

Branche

Diagnostics & Research (53)

Telefon

(513) 579-9911

Adresse

5375 MEDPACE WAY, CINCINNATI, OH

Mitarbeiter

6,200

Twitter

@WorkatMedpace

Nächster Verdiensttermin

2025-10-22

Neueste SEC-Einreichungen

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, IDXX, A, WAT

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MEDP Medpace Holdings Inc	428.03	11.81B	2.36B	433.01M	676.77M	14.30
TMO Thermo Fisher Scientific Inc	504.82	191.54B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	212.58	151.94B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	629.35	49.28B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	125.81	35.32B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	323.37	31.37B	3.17B	642.63M	539.81M	10.77

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-10	Hochstufung	Robert W. Baird	Neutral → Outperform
2025-11-13	Eingeleitet	BMO Capital Markets	Market Perform
2025-10-02	Herabstufung	Barclays	Equal Weight → Underweight
2025-09-03	Herabstufung	Rothschild & Co Redburn	Buy → Neutral
2025-07-29	Herabstufung	UBS	Neutral → Sell
2025-07-23	Herabstufung	TD Cowen	Hold → Sell
2025-06-24	Eingeleitet	Barclays	Equal Weight
2025-04-22	Herabstufung	William Blair	Outperform → Mkt Perform
2025-04-14	Herabstufung	TD Cowen	Buy → Hold
2025-03-24	Eingeleitet	Leerink Partners	Market Perform
2024-10-23	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-10-14	Eingeleitet	Redburn Atlantic	Buy
2024-09-27	Herabstufung	UBS	Buy → Neutral
2024-09-25	Herabstufung	Jefferies	Buy → Hold
2024-08-01	Eingeleitet	Truist	Hold
2024-05-29	Eingeleitet	TD Cowen	Buy
2024-05-28	Eingeleitet	Mizuho	Buy
2024-04-23	Hochstufung	Jefferies	Hold → Buy
2024-03-18	Eingeleitet	Deutsche Bank	Hold
2024-02-15	Hochstufung	UBS	Neutral → Buy
2023-10-24	Hochstufung	Robert W. Baird	Neutral → Outperform
2023-05-08	Hochstufung	Guggenheim	Neutral → Buy
2022-10-27	Hochstufung	UBS	Sell → Neutral
2022-09-07	Eingeleitet	UBS	Sell
2022-05-24	Eingeleitet	Guggenheim	Neutral
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-10-02	Hochstufung	Truist	Hold → Buy
2020-06-08	Hochstufung	Robert W. Baird	Underperform → Neutral
2020-05-13	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-04-30	Hochstufung	SunTrust	Sell → Hold
2020-04-20	Herabstufung	Robert W. Baird	Neutral → Underperform
2020-03-17	Herabstufung	SunTrust	Hold → Sell
2020-01-27	Herabstufung	SunTrust	Buy → Hold
2018-10-31	Hochstufung	SunTrust	Hold → Buy
2018-09-17	Eingeleitet	SunTrust	Hold
2018-07-31	Hochstufung	William Blair	Mkt Perform → Outperform
2017-11-01	Herabstufung	William Blair	Outperform → Mkt Perform
2017-09-29	Eingeleitet	Raymond James	Mkt Perform
2017-07-10	Herabstufung	KeyBanc Capital Mkts	Overweight → Sector Weight

Alle ansehen

Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten

08:03 AM

Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts - MSN

08:03 AM

Feb 13, 2026

Jefferies Upgrades Medpace to Buy From Hold, $560 Price Target - marketscreener.com

Feb 13, 2026

Prescott Group Capital Management L.L.C. Cuts Position in Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 13, 2026

Medpace Holdings, Inc. (NASDAQ:MEDP) Just Reported, And Analysts Assigned A US$491 Price Target - simplywall.st

Feb 13, 2026

Medpace (MEDP) Q4 2025 Earnings Call Transcript - AOL.com

Feb 13, 2026

Feb 12, 2026

Assessing Medpace (MEDP) Valuation After A Sharp Share Price Pullback And Backlog Concerns - Yahoo Finance

Feb 12, 2026

What’s the fair value of Medpace Holdings Inc. stockJuly 2025 Action & Weekly Setup with ROI Potential - mfd.ru

Feb 12, 2026

Krilogy Financial LLC Purchases New Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 12, 2026

Feb 11, 2026

Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 11, 2026

Baird upgrades Medpace stock rating to Outperform on AI potential By Investing.com - Investing.com Australia

Feb 11, 2026

4 Analysts Have This To Say About Medpace Hldgs - Benzinga

Feb 11, 2026

Can Medpace Holdings Inc. continue delivering strong returns2025 Momentum Check & Long-Term Growth Portfolio Plans - mfd.ru

Feb 11, 2026

Baird upgrades Medpace stock rating to Outperform on AI potential - Investing.com

Feb 11, 2026

Deutsche Bank Adjusts Medpace Price Target to $480 From $600, Maintains Hold Rating - marketscreener.com

Feb 11, 2026

Truist Securities Adjusts Price Target on Medpace to $539 From $555, Maintains Hold Rating - marketscreener.com

Feb 11, 2026

Medpace stock price target lowered to $460 by BMO Capital - Investing.com South Africa

Feb 11, 2026

Medpace (NASDAQ:MEDP) Given New $500.00 Price Target at Barclays - MarketBeat

Feb 11, 2026

Medpace stock price target lowered to $460 by BMO Capital By Investing.com - Investing.com India

Feb 11, 2026

Can Medpace Holdings Inc. lead its sector in growthJuly 2025 Snapshot & Weekly High Return Opportunities - mfd.ru

Feb 11, 2026

Leerink Partners Issues Pessimistic Forecast for Medpace (NASDAQ:MEDP) Stock Price - MarketBeat

Feb 11, 2026

Medpace (NASDAQ:MEDP) Price Target Lowered to $539.00 at Truist Financial - MarketBeat

Feb 11, 2026

Madison Asset Management LLC Sells 4,419 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 11, 2026

Candriam S.C.A. Decreases Stake in Medpace Holdings, Inc. $MEDP - MarketBeat

Feb 11, 2026

Medpace Q4 2025 slides: Revenue up 32%, stock tumbles on guidance By Investing.com - Investing.com South Africa

Feb 11, 2026

Medpace Q4 Earnings Beat Overshadowed by Cancellation Spike - AlphaStreet News

Feb 11, 2026

Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - Yahoo Finance

Feb 11, 2026

Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus

Feb 11, 2026

Feb 10, 2026

Medpace (MEDP) Stock Declines Significantly - GuruFocus

Feb 10, 2026

Medpace Q4 2025 slides: Revenue up 32%, stock tumbles on guidance - Investing.com Nigeria

Feb 10, 2026

Medpace Holdings’ Earnings Call Signals Growth Amid Volatility - TipRanks

Feb 10, 2026

Leerink Partners lowers Medpace stock price target on elevated cancellations By Investing.com - Investing.com South Africa

Feb 10, 2026

Medpace (MEDP) Sees Upgrade Despite Stock Decline - GuruFocus

Feb 10, 2026

Leerink Partners lowers Medpace stock price target on elevated cancellations - Investing.com

Feb 10, 2026